Research Article| Volume 30, ISSUE 2, P222-227, February 1999

Short-term cyclosporine induces a remission of autoimmune hepatitis in children


      Background/Aims: The current immunosuppressive treatment of patients with autoimmune hepatitis consists of prednisone and azathioprine. High doses of prednisone used to obtain the remission of the disease are associated with serious adverse effects. To avoid harmful consequences of prednisone therapy, we proposed to treat patients with oral cyclosporine to obtain the remission of the inflammatory process.
      Methods: This is a pilot, multinational, multicenter, clinical trial involving children with autoimmune hepatitis. Thirty-two children were recruited, who according to international criteria were considered as having definite autoimmune hepatitis. Cyclosporine alone was administered for 6 months, followed by combined low doses of prednisone and azathioprine for 1 month, after which cyclosporine was discontinued. Biochemical remission of the disease was established by the follow-up of serum transaminase activity levels. Growth parameters and adverse effects of the treatment were recorded.
      Results: Two patients were withdrawn from the study: one for non-compliance and the other for liver failure which did not improve with cyclosporine. Of the 30 remaining patients, 25 normalized alanine aminotransferase activity levels by 6 months and all the patients by 1 year of treatment. Z-scores for height showed a trend towards improvement during treatment. Adverse effects of cyclosporine weremild and disappeared during weaning off the medication.
      Conclusions: Cyclosporine induced the biochemical remission of the hepatic inflammatory/necrotic process in children with autoimmune hepatitis, with few and well-tolerated adverse effects.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Krawitt EL
        Autoimmune hepatitis.
        N Engl J Med. 1996; 334: 897-903
        • Homberg J-C
        • Abuaf N
        • Bernard O
        • Islam S
        • Alvarez F
        • Khalil S
        • et al.
        Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of “autoimmune” hepatitis.
        Hepatology. 1987; 7: 1333-1339
        • Maggiore G
        • Bernard O
        • Homberg J-C
        • Hadchouel M
        • Alvarez F
        • Hadchouel P
        • et al.
        Liver disease associated with anti-liver-kidney microsome antibody in children.
        J Pediatr. 1986; 108: 399-404
        • Maggiore G
        • Veber F
        • Bernard O
        • Hadchouel M
        • Homberg J-C
        • Alvarez F
        • et al.
        Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents.
        J Pediatr Gastroenterol Nutr. 1993; 17: 376-381
        • Gregorio GV
        • Portmann B
        • Reid F
        • Donaldson PT
        • Doherty DG
        • McCartney M
        • et al.
        Autoimmune hepatitis in childhood: a 20-year experience.
        Hepatology. 1997; 25: 541-547
        • Sanchez-Urdazpal L
        • Czaja AJ
        • van Hock B
        • Krom RA
        • Weisner RH
        Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis.
        Hepatology. 1991; 15: 215-221
        • Czaja AJ
        Diagnosis, prognosis and treatment of classical autoimmune chronic active hepatitis.
        in: Krawitt EL Wiesner RH Autoimmune Liver Diseases. Raven Press, New York1991: 143-166
        • Johnson PJ
        • McFarlane IG
        • Williams R
        Azathioprine for longterm maintenance of remission in autoimmune hepatitis.
        N Engl J Med. 1995; 333: 958-963
        • Debray D
        • Maggiore G
        • Bernard O
        Traitement par la ciclosporine des hépatites autoimmune (HAI) de l'enfant.
        Gastroenterol Clin Biol. 1995; 19: A7
        • Stiller CR
        • Dupré J
        • Gent M
        • Jenner MR
        • Keown PA
        • Laupacis A
        • et al.
        Effects of cyclosporine immunosuppression in insulindependent diabetes mellitus of recent onset.
        Science. 1984; 223: 1362-1367
        • Assan R
        • Feutren G
        • Sirmai J
        • Laborie C
        • Boitard C
        • Veriau P
        • et al.
        Plasma C-peptide levels and clinical remissions in recent onset type 1 diabetic patient treated with cyclosporine A and insulin.
        Diabetes. 1990; 39: 768-774
        • Johnson PJ
        • McFarlane IG
        Meeting Report: International Autoimmune Hepatitis Group.
        Hepatology. 1993; 18: 998-1005
        • Desmet VJ
        • Gerber M
        • Hoofnagle JH
        • Manns M
        • Scheuer PJ
        Classification of chronic hepatitis: diagnosis, grading and staging.
        Hepatology. 1994; 19: 1513-1520
        • Dumn SP
        • Cooney GF
        • Kulinsky A
        • Falkenstein K
        • Pierson A
        • Elder CA
        • et al.
        Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
        Transplantation. 1995; 60: 1438-1442
        • Maggiore G
        • Alvarez F
        • Bernard O
        Autoimmune chronic hepatitis.
        in: Buts J-P Sokal EM Management of digestive and liver disorders in infants and children. Elsevier, Amsterdam1993: 567-575
        • Nouri-Aria KT
        • Hegarty JE
        • Alexander GJM
        • Eddleston ALWF
        • Williams R
        Effects of corticosteroids on suppressor-cell activity in“autoimmune” and viral chronic active hepatitis.
        N Engl J Med. 1982; : 1301-1304
        • Hyams JS
        • Ballow M
        • Leichtner AN
        Cyclosporine treatment of autoimmune chronic active hepatitis.
        Gastroenterology. 1987; 93: 890-893
        • Jackson LD
        • Song E
        Cyclosporin in the treamtent of corticosteroid resistant autoimmune hepatitis.
        Gut. 1995; 36: 459-461
        • Paradis K
        • El Edreesi M
        • St-Vil D
        • Laberge JM
        • Dupuis C
        • Rasquin-Weber A
        Cyclosporine kinetics in pediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate.
        Transplant Proc. 1994; 26: 2777-2778